Literature DB >> 20006812

Risk analysis and an alternative protocol for reduction of screening for retinopathy of prematurity.

Michael B Yang1, Edward F Donovan.   

Abstract

PURPOSE: To determine whether a multivariate risk model can select infants with low-risk eyes for an alternative protocol that reduces retinopathy of prematurity (ROP) screening without loss of effectiveness.
METHODS: This was a retrospective, nonrandomized, comparative study. We assigned 712 eyes of 357 premature infants of 401-1,250 g birth weights as high or low risk for prethreshold or threshold ROP using a risk model with variables of birth weight, gestational age, multiple birth, race, and gender. Using simulations, infants with high-risk eyes (p > or = 0.15) were screened conventionally, while those with low-risk eyes were screened with the 35q3 protocol (initial examination at 35 weeks postmenstrual age followed by screening every 3 weeks, with increased or decreased intervals based on ROP severity). The resultant reduction in ROP screening and the delay to detection of severe ROP were calculated.
RESULTS: The 35q3 protocol reduced the mean number of eye examinations per infant in the overall population by 13.4% (p = 0.0051). No eyes had a delay to the detection of threshold or type 1 zone 1 ROP. Of a total of 57 type 1 ROP eyes, 2 eyes with type 1 zone 2 ROP were delayed to detection by 1 week. As our study was done prior to the Early Treatment of ROP study, the 2 eyes were observed and regressed without progression to threshold ROP.
CONCLUSIONS: A risk-based alternative screening protocol increased the efficiency of ROP screening for infants of 401-1,250 g birth weight without an apparent loss of effectiveness. This investigational approach requires further validation by multicenter studies.

Entities:  

Mesh:

Year:  2009        PMID: 20006812     DOI: 10.1016/j.jaapos.2009.10.002

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  4 in total

1.  Risk Score for Predicting Treatment-Requiring Retinopathy of Prematurity (ROP) in the Telemedicine Approaches to Evaluating Acute-Phase ROP Study.

Authors:  Gui-Shuang Ying; Deborah VanderVeen; Ebenezer Daniel; Graham E Quinn; Agnieshka Baumritter
Journal:  Ophthalmology       Date:  2016-08-02       Impact factor: 12.079

Review 2.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

3.  Validation of the Colorado Retinopathy of Prematurity Screening Model.

Authors:  Emily A McCourt; Gui-Shuang Ying; Anne M Lynch; Alan G Palestine; Brandie D Wagner; Erica Wymore; Lauren A Tomlinson; Gil Binenbaum
Journal:  JAMA Ophthalmol       Date:  2018-04-01       Impact factor: 7.389

4.  Length of day during early gestation as a predictor of risk for severe retinopathy of prematurity.

Authors:  Michael B Yang; Sujata Rao; David R Copenhagen; Richard A Lang
Journal:  Ophthalmology       Date:  2013-10-15       Impact factor: 12.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.